Menu
Back to User profile » Prof. Dr. Dong Wang
Papers published by Prof. Dr. Dong Wang:
The correlation of BER protein, IRF3 with CD8+ T cell and their prognostic significance in upper tract urothelial carcinoma
Wang L, Yang B, Rao W, Xiao H, Wang D, Jiang J
OncoTargets and Therapy 2019, 12:7725-7735
Published Date: 24 September 2019
MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
Liang W, Li C, Li M, Wang D, Zhong Z
OncoTargets and Therapy 2019, 12:7203-7214
Published Date: 3 September 2019
HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma
Zhang L, Li M, Deng B, Dai N, Feng Y, Shan J, Yang Y, Mao C, Huang P, Xu C, Wang D
Cancer Management and Research 2019, 11:2605-2616
Published Date: 1 April 2019
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
Li C, Xiong Y, Yang X, Wang L, Zhang S, Dai N, Li M, Ren T, Yang Y, Zhou SF, Gan L, Wang D
Drug Design, Development and Therapy 2015, 9:1773-1783
Published Date: 24 March 2015
Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
Qing Y, Li Q, Ren T, Xia W, Peng Y, Liu GL, Luo H, Yang YX, Dai XY, Zhou SF, Wang D
Drug Design, Development and Therapy 2015, 9:901-909
Published Date: 16 February 2015
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway
Ren T, Shan J, Qing Y, Qian C, Li Q, Lu G, Li M, Li C, Peng Y, Luo H, Zhang S, Zhang W, Wang D, Zhou SF
Drug Design, Development and Therapy 2014, 8:2517-2529
Published Date: 12 December 2014